|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
Repay Holdings Corp (Name of Issuer) |
Common Stock (Title of Class of Securities) |
(CUSIP Number) |
Alex Vezendan 3889 Maple Avenue, Suite 220 Dallas, TX, 75219 913-908-4943 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
04/10/2026 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Veradace Capital Management LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
 (a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,355,504.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
8.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN, IA |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Veradace Partners LP | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,355,504.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
8.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Alexander Vezendan | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,355,504.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
8.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
John Conlin | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,355,504.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
8.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock |
| (b) | Name of Issuer:
Repay Holdings Corp |
| (c) | Address of Issuer's Principal Executive Offices:
3060 PEACHTREE ROAD NW, SUITE 1100, Atlanta,
GEORGIA
, 30305. |
| Item 2. | Identity and Background |
| (a) | This statement is being jointly filed by and on behalf of each of Veradace Capital Management LLC, a Delaware limited
liability company ("Veradace"), Veradace Partners L.P., a Delaware limited partnership (the "Fund"), Alexander Vezendan,
and John Conlin.
The Fund is the record and direct beneficial owner of the securities covered by this statement. As the investment adviser to
the Fund, Veradace may be deemed to beneficially own the securities covered by this statement. Messrs. Vezendan and
Conlin are the Principals of and may be deemed to beneficially own securities owned by, Veradace. The total number of shares owned consists of 7,245,104 shares of common stock and options to purchase 110,400 shares of common stock.
Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an
admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial
owner of any securities covered by this statement. Each reporting person may be deemed to be a member of a group with
respect to the issuer or securities of the issuer for the purposes of Section 13(d) or 13(g) of the Act. Each reporting person
declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is,
for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act
together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring,
holding, or disposing of securities of the issuer or otherwise with respect to the issuer or any securities of the issuer or (ii) a
member of any group with respect to the issuer or any securities of the issuer |
| (b) | 3889 Maple Avenue, Suite 220, Dallas, TX 75219 |
| (c) | Each of the Reporting Persons is principally engaged in the business of acquiring, holding, voting and disposing of various public securities investments |
| (d) | During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
| (e) | During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (f) | Veradace and the Fund are each organized under the laws of the State of Delaware. Messrs. Vezendan and Conlin are both citizens of the United States. |
| Item 3. | Source and Amount of Funds or Other Consideration |
As of April 8, 2026, the Fund, the record and direct beneficial owner of the securities covered by this statement, held voting and dispositive power over 7,245,104 shares of common stock of the Issuer ("Shares") and options to acquire 110,400 Shares (such shares and options collectively, the "Securities"), representing a combined total of 8.6 percent of the Issuer's outstanding Class A Shares. All calculations of beneficial ownership percentages in this statement are based on 85,880,982 Shares outstanding as of March 4, 2026, as disclosed by the Issuer in its Form 10-K filed with the SEC on March 9, 2026. Relevant transactions leading up to this date, as well as the respective price per share of each transaction, are set forth on Schedule A to this statement. Each of these transactions was executed through the open market. The funds for the purchase of the Securities came from the working capital of the Fund. The aggregate purchase price of the Securities reported herein was approximately $31,342,416. No borrowed funds were used to purchase the Securities, other than under margin accounts with a brokerage firm in the ordinary course of business. Positions in Issuer securities may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts. Such margin accounts may from time to time have debit balances. In addition, since other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase the Securities. | |
| Item 4. | Purpose of Transaction |
Veradace originally acquired beneficial ownership of the Shares of the Issuer for investment purposes
and filed a Schedule 13G on November 5, 2025 based on a passive investment intent.
Veradace evaluates on an ongoing basis its investment in the Issuer and its options with respect to
such investment, and now believe that additional changes may be necessary for the Issuer to
maximize shareholder value. On April 8, 2026, Veradace shared its concerns with the Issuer
regarding the Issuer's performance over the last several years, the shareholder opposition to the
KUBRA Data Transfer LTD acquisition, and the absence of any meaningful shareholder perspective
on its board of directors (the "Board"). Veradace indicated its desire for two new shareholdersupported
directors to be added to the Board.
Veradace intends to continue to engage in dialogue with the Issuer regarding potential Board
candidates and the opportunity for the Board to benefit from fresh perspectives with respect to
investor credibility, capital allocation, and overall value maximization.
As noted above, Veradace intends to evaluate on an ongoing basis its investment in the Issuer and
its options with respect to such investment. In connection with such evaluation, the Reporting
Persons may communicate publicly or privately with members of the Board and/or senior
management of the Issuer, other stockholders, knowledgeable industry or market observers, or other
third parties with respect to this investment. As part of such evaluation and any such communications,
the Reporting Persons may make recommendations, suggestions, or proposals to and may engage in
discussions with the Issuer or other third parties (including other stockholders) that may relate to or
result in one or more of the matters specified in clauses (a) through U) of Item 4 of Schedule 13D,
including, but not limited to, changes in the composition of the Board, changes in the strategic direction and future plans of the Issuer and other opportunities involving the Issuer as a means of
enhancing shareholder value.
Except as set forth herein, none of the Reporting Persons has any plans or proposals that relate to or
would result in any of the transactions described in subparagraphs (a) through U) of Item 4 of
Schedule 13D. Depending on various factors, including the Issuer's financial position, prospects and
strategic direction, the outcome of the matters referenced above, other developments concerning the
Issuer, actions taken by the Board, price levels of the Shares, other investment opportunities
available to the Reporting Persons, conditions in the securities markets and general economic and
industry conditions, the Reporting Persons may in the future take such actions with respect to their
investment in the Issuer as it deems appropriate, including, without limitation, (i) acquiring additional
securities of the Issuer in the open market or in privately negotiated transactions, (ii) disposing of all
or a portion of its securities, and (iii) enter into hedging, derivative or other arrangements with respect
to its economic exposure to the Issuer's securities. The Reporting Persons reserve the right to
change their views with respect to the Issuer and to take any action with respect to their investment
permitted by law. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | The aggregate number and percentage of the class of securities identified pursuant to Item 1 beneficially owned by each Reporting Person as of the time of filing, is stated in Items 11 and 13 on the cover page(s) hereto. |
| (b) | The Reporting Persons may be deemed to share voting and dispositive power over 7,245,104Shares and options to acquire an additional 110,400 Shares, representing beneficial ownership of a combined total of 8.4 percent of the outstanding Shares. |
| (c) | The transactions effected by the Reporting Persons in the Shares during the past 60 days are set forth on Schedule A to this statement. Each of these transactions was executed through the open market. |
| (d) | No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Securities. |
| (e) | Not applicable. |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
The information set forth in Item 4 above is incorporated by reference in its entirety in this Item 6. The Fund, through open market transactions between September 25, 2025 and November 4, 2025, purchased options to acquire 110,400 Shares and sold put options covering the same number of Shares. All of the Options are American-style and expire on June 30, 2026. The exercise prices for the Options are as set forth below:
Option Exercise Price
110,400 Shares (Call) $7.50 per Share
The Reporting Persons do not have any contract, arrangement, understanding or relationship with any person with respect to securities of the Issuer that is not described herein. | |
| Item 7. | Material to be Filed as Exhibits. |
Attached |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|